Concepedia

Hedy Teppler

HT

Statistics

Publications

57

Citations

6.9K

H-Index

33

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Rockefeller University

Harvard University

University of Bonn

Hedy Teppler is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in antiretroviral therapy, antiviral therapy, and clinical pharmacology.

Publications per year

1992–2023

57

Publications

57

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz et al. · New England Journal of Medicine · 2004 · 921 citations · Full text

, , +17

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Roy T. Steigbigel, David A. Cooper, Princy Kumar et al. · New England Journal of Medicine · 2008 · 686 citations · Full text

, , +17

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

David A. Cooper, Roy T. Steigbigel, José M. Gatell et al. · New England Journal of Medicine · 2008 · 507 citations · Full text

, , +14

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

S. Park, Rosemarie Kelly, Jennifer Nielsen Kahn et al. · Antimicrobial Agents and Chemotherapy · 2005 · 432 citations

, , +17

Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection

Martin Markowitz, Bach‐Yen Nguyen, Eduardo Gotuzzo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 407 citations

, , +17

1–5 of 57